June 04, 2026 — RNews

#rsv — Thursday, June 04, 2026 (1 items)

hot top new

← prev day next day →

0

Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged >/=50 years: a phase 3, randomized, non-inferiority trial. (academic.oup.com)

Bonten M … Van der Wielen M Clinical Infectious Diseases 2026-06-04

#covid-19 #vaccination #immunogenicity #safety #rsv